NO20034667L - Arylsulfonamider som antivirale midler - Google Patents

Arylsulfonamider som antivirale midler

Info

Publication number
NO20034667L
NO20034667L NO20034667A NO20034667A NO20034667L NO 20034667 L NO20034667 L NO 20034667L NO 20034667 A NO20034667 A NO 20034667A NO 20034667 A NO20034667 A NO 20034667A NO 20034667 L NO20034667 L NO 20034667L
Authority
NO
Norway
Prior art keywords
sup
arylsulfonamides
antivirals
substituents
processes
Prior art date
Application number
NO20034667A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034667D0 (no
Inventor
Tobias Wunberg
Wolfgang Bender
Peter Eckenberg
Sabine Hallenberger
Kerstin Henninger
Joerg Keldenich
Armin Kern
Siegfried Raddatz
Juergen Reefschlaeger
Gunter Schmidt
Holger Zimmermann
Franz Zumpe
Martin Radtke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10148598A external-priority patent/DE10148598A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20034667D0 publication Critical patent/NO20034667D0/no
Publication of NO20034667L publication Critical patent/NO20034667L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20034667A 2001-04-19 2003-10-17 Arylsulfonamider som antivirale midler NO20034667L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19
DE10148598A DE10148598A1 (de) 2001-04-19 2001-10-02 Neue Arylsulfonamide als antivirale Mittel
PCT/EP2002/003858 WO2002085869A1 (de) 2001-04-19 2002-04-08 Arylsulfonamide als antivirale mittel

Publications (2)

Publication Number Publication Date
NO20034667D0 NO20034667D0 (no) 2003-10-17
NO20034667L true NO20034667L (no) 2003-12-12

Family

ID=26009118

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034667A NO20034667L (no) 2001-04-19 2003-10-17 Arylsulfonamider som antivirale midler

Country Status (20)

Country Link
US (1) US7115612B2 (https=)
EP (1) EP1383749B1 (https=)
JP (1) JP4480941B2 (https=)
CN (1) CN1516695A (https=)
AT (1) ATE308529T1 (https=)
BG (1) BG108272A (https=)
BR (1) BR0209054A (https=)
CA (1) CA2444123C (https=)
DE (1) DE50204780D1 (https=)
EE (1) EE200300515A (https=)
ES (1) ES2252455T3 (https=)
HU (1) HUP0303813A3 (https=)
IL (1) IL158324A0 (https=)
MX (1) MXPA03009548A (https=)
NO (1) NO20034667L (https=)
PL (1) PL363990A1 (https=)
RU (1) RU2003133750A (https=)
SK (1) SK12662003A3 (https=)
UY (1) UY27263A1 (https=)
WO (1) WO2002085869A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20050168A2 (en) * 2002-08-23 2005-10-31 Rigel Pharmaceuticals Pyridyl substituted heterocycles useful for treating or preventing hcv infection
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
EP4101846B1 (en) 2003-04-11 2023-08-02 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
DE102006009928A1 (de) 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituierte Arylsulfonamide
EP2387995A1 (en) 2006-03-30 2011-11-23 PTC Therapeutics, Inc. Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
US20100240657A1 (en) * 2007-07-02 2010-09-23 Boehringer Ingelheim International Gmbh Chemical compounds
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2202232A1 (en) * 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
AR083431A1 (es) * 2010-06-28 2013-02-27 Bayer Cropscience Ag Compuestos heterociclicos como pesticidas
JP2013531687A (ja) 2010-07-16 2013-08-08 パーデュー、ファーマ、リミテッド、パートナーシップ ナトリウムチャネル遮断剤としてのピリジン化合物
WO2013136170A1 (en) 2012-03-16 2013-09-19 Purdue Pharma L.P. Substituted pyridines as sodium channel blockers
US9284310B2 (en) 2012-11-03 2016-03-15 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
JP6372666B2 (ja) 2012-11-03 2018-08-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング サイトメガロウイルスの阻害剤
WO2014096941A1 (en) 2012-12-20 2014-06-26 Purdue Pharma L.P. Cyclic sulfonamides as sodium channel blockers
TWI695717B (zh) 2014-03-06 2020-06-11 美商 Ptc 治療公司 1,2,4-二唑苯甲酸之鹽及醫藥組合物
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
JP6749344B2 (ja) * 2015-02-13 2020-09-02 アジエンダ・オスペダリエラ・ウニベルシタリア・セネーゼ 治療剤としてのヒトヘリカーゼddx3阻害剤
CN108348527A (zh) 2015-10-30 2018-07-31 Ptc医疗公司 用于治疗癫痫的方法
BR112019020252A2 (pt) * 2017-03-31 2020-04-22 Perenna Pharmaceuticals Inc compostos úteis como inibidores de alcat 1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
CN1347411A (zh) * 1999-04-19 2002-05-01 盐野义制药株式会社 含有噁二唑环的磺酰胺衍生物

Also Published As

Publication number Publication date
CA2444123A1 (en) 2002-10-31
EE200300515A (et) 2004-02-16
US7115612B2 (en) 2006-10-03
PL363990A1 (en) 2004-11-29
EP1383749A1 (de) 2004-01-28
BG108272A (bg) 2004-10-29
RU2003133750A (ru) 2005-05-10
CN1516695A (zh) 2004-07-28
WO2002085869A1 (de) 2002-10-31
NO20034667D0 (no) 2003-10-17
CA2444123C (en) 2010-09-21
HUP0303813A2 (hu) 2004-03-29
MXPA03009548A (es) 2004-05-24
UY27263A1 (es) 2002-11-29
BR0209054A (pt) 2004-04-20
US20040176374A1 (en) 2004-09-09
EP1383749B1 (de) 2005-11-02
JP4480941B2 (ja) 2010-06-16
ATE308529T1 (de) 2005-11-15
JP2004531536A (ja) 2004-10-14
DE50204780D1 (de) 2005-12-08
IL158324A0 (en) 2004-05-12
ES2252455T3 (es) 2006-05-16
HUP0303813A3 (en) 2005-05-30
SK12662003A3 (sk) 2004-04-06

Similar Documents

Publication Publication Date Title
NO20034667L (no) Arylsulfonamider som antivirale midler
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
DK1200418T3 (da) Nematodicide trifluorbutener
DE60212949D1 (de) Antivirale pyrazolopyridin verbindungen
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
AU2003228770A1 (en) Substituted pyrazolopyrimidines
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
BR9912392A (pt) Benzoilcicloexanodionas substituìdas
ATE300541T1 (de) Pyrazolopyridinderivate
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
NO20054787L (no) Indenderivater som farmasotiske midler
ATE297903T1 (de) Substituierte phenyluracile
SE0101038D0 (sv) Novel compounds
MA27501A1 (fr) Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3
BG104617A (en) Novel naphthyl-substituted and anilide-substituted sulfonamides
ATE373000T1 (de) Pyrazolopyridin-derivate als antiherpesmittel
BR0012751A (pt) Benzofuranos serotonérgicos
DE60201074D1 (en) Pyrazolopyridinderivate
HRP20010798B1 (hr) Postupci priprave pesticidnih međuprodukata
SE9904128D0 (sv) Novel compounds
MXPA02011234A (es) Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application